Daniel Lorrain
Fortune : 2 M $ au 30/06/2026
Fortune : 2 M $ au 30/06/2026
Daniel S.
Lorrain is the founder of Contineum Therapeutics, Inc., founded in 2017, serving as Chief Scientific Officer since 2018.
Former jobs include Senior Director at Amira Pharmaceuticals, Inc. from 2005 to 2010, and Vice President-Biology at Inception Sciences, Inc. from 2016 to 2018.
Education includes an undergraduate degree conferred in 1991 and a doctorate conferred in 1997, both from the State University of New York at Buffalo.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/07/2026 | 145 312 ( 0,44 % ) | 2 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Fondateur | 09/05/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Directeur/Membre du Conseil | 10/01/2018 |
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Directeur/Membre du Conseil | 01/11/2010 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national